Assembly Biosciences Inc

Market cap: $80,322,317

Exchange: NAS

Sector: Health Technology

Share
Tweet

Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses in two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin and Derek A. Small on October 7, 2005 and is headquartered in South San Francisco, CA.

Key Statistics

Company Name

Assembly Biosciences Inc

Average Volume (10 days)

19,133

Average Volume (30 days)

20,478

Moving Average (50 days)

$13.18

Moving Average (200 days)

$10.81

Ex-Divided Date

n/a

Dividend Yield

0

P/E Ratio

0

Market Cap

80,322,317

Shares Outstanding

5,482,752

52-Week High Split Adjust Only

20.04

52-Week Low Split Adjust Only

7.69

Employee Count

110

Beta

1.2814

Next Earnings Date

2024-05-09

TTM Dividend Rate Per Share

0

Price Changes

Past 5 days

0.06%

Past 30 days

0.15%

Past 3 months

0.51%

Past 6 months

0.64%

Past year

0.49%

Past 2 years

-0.41%

Past 5 years

-0.94%

Max % Change

-0.54%

PEER GROUP COMPARATIVE PERFORMANCE

NameTickerPrice/Sales (ttm)Price/Book (ttm)Forward P/EPEG RatioEV/Revenue
Assembly Biosciences IncASMBn/an/a-1.5n/an/a
Peer AvgN/A1.464.4911.41.461.39
Ironwood Pharmaceuticals Inc - Class AIRWD4.7017.0110.94.704.70
Cumberland Pharmaceuticals Inc.CPIX1.120.9436.91.120.87
Agile Therapeutics IncAGRXn/an/a-2.3n/an/a